A new oral weight-loss drug from Pfizer could be more effective than the popular Ozempic injection, based on clinical trial results.

Share:
More In Business
Inflation Worries Aren’t Quite Over Yet
Mario Veneroso, Kingsview Asset Management Partner, weighs in on the latest economic data and whether the market is pricing in too many rate cuts for the coming year.
Load More